通过调节JAK2/STAT3/c-Myc通路,FCGBP促进质瘤的生长
Jin Zheng1, Yu Xin Rao1, Hui Zheng2
1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Cancer medicine
|February 15, 2026
概括
补充C1G结合蛋白 (FCGBP) 的Fc片段促进质瘤的进展,并与预后不佳有关. 这种FCGBP激活JAK2/STAT3通路表明它是质瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 补充C1G结合蛋白 (FCGBP) 的Fc片段与各种癌症有关.
- FCGBP在质瘤发育和进展中的特定作用需要进一步阐明.
研究的目的:
- 为了研究FCGBP在质瘤中的表达和功能.
- 确定FCGBP与质瘤患者的结局之间的关联.
- 探索潜在的分子机制,包括JAK2/STAT3通路.
主要方法:
- 使用定量实时PCR (qRT-PCR),西部抹杀 (WB) 和免疫组织化学 (IHC) 来评估FCGBP表达.
- 用功能测定和动物模型来研究FCGBP在质瘤中的作用.
- 研究了FCGBP对Janus Kinase 2/信号转换器和转录3激活器 (JAK2/STAT3) 途径的影响.
主要成果:
- 发现FCGBP在质瘤组织中显著过度表达.
- 较高的FCGBP水平与较高的瘤等级和较差的临床结果相关.
- 通过激活JAK2/STAT3信号通路,FCGBP促进质瘤细胞的攻击性.
结论:
- FCGBP在驱动质瘤侵略性和导致预后不佳方面发挥着关键作用.
- FCGBP代表了质瘤治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K
TGF - β Signaling Pathway
10.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
The JAK-STAT Signaling Pathway
13.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.1K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K


